Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Nunes Anne. Officer active across 1 company, notably Anika Therapeutics, Inc.. Cumulatively, 7 disclosures have been recorded. Activity tracked since 1 October 2023. The latest transaction was filed on 17 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Nunes Anne is an insider linked to Anika Therapeutics, Inc., where she holds the role of SVP, Chief Operations Officer. She has 7 filings in total, and in the recent filings tracked, the most common transaction nature is option exercise, with a period ranging from 2023-10-03 to 2025-03-18.